GL1X · GenesisL1 explorer

UniProt P0A017

Dihydrofolate reductase (P0A017)

Dihydrofolate reductase (UniProt P0A017), EC 1.5.1.3: 89 experimental structures and 1 predicted model on GenesisL1, 16 ligands bound, 2 pockets. Binding sites, druggability and experiment against prediction (TM-score) in GL1X.

UniProt
P0A017
Protein
Dihydrofolate reductase
EC
1.5.1.3
Experimental structures
89
Predicted models
1
Ligands
16
Pockets
2 · 2 records with a druggable one

Structures

90 records of P0A017 in the MolNFT archive: 89 experimental, 1 predicted.

EntryTitleMethodChainsLigandsPockets
2W9GWild-type Staphylococcus aureus DHFR in complex with NADPH and trimethoprimx-ray diffractionA——
2W9GWild-type staphylococcus aureus DHFR in complex with NADPH and trimethoprimx-ray diffractionA——
2W9HWild-type Staphylococcus aureus DHFR in complex with trimethoprimx-ray diffractionA——
2W9HWild-type staphylococcus aureus DHFR in complex with trimethoprimx-ray diffractionA——
3FRAStaphylococcus aureus F98Y DHFR complexed with iclaprimx-ray diffractionX——
3FRAStaphylococcus aureus F98Y DHFR complexed with iclaprimx-ray diffractionX——
3FRBS. aureus F98Y DHFR complexed with TMPx-ray diffractionX——
3FRBS. aureus F98Y DHFR complexed with tmpx-ray diffractionX——
3FRDS. aureus DHFR complexed with NADPH and folatex-ray diffractionX——
3FRDS. aureus DHFR complexed with NADPH and folatex-ray diffractionX——
3FRES. aureus DHFR complexed with NADPH and TMPx-ray diffractionX——
3FRES. aureus DHFR complexed with NADPH and tmpx-ray diffractionX——
3FRFS. aureus DHFR complexed with NADPH and iclaprimx-ray diffractionX——
3FRFS. aureus DHFR complexed with NADPH and iclaprimx-ray diffractionX——
3FY8Crystal Structure of Staph. aureus DHFR complexed with NADPH and AR-101x-ray diffractionX——
3FY8Crystal structure of staph. aureus DHFR complexed with NADPH and ar- 101x-ray diffractionX——
3FY9Staph. aureus DHFR F98Y complexed with AR-102x-ray diffractionX——
3FY9Staph. aureus DHFR F98Y complexed with ar-102x-ray diffractionX——
3FYVStaph. aureus DHFR complexed with NADPH and AR-102x-ray diffractionX——
3FYVStaph. aureus DHFR complexed with NADPH and ar-102x-ray diffractionX——
3FYWStaph. aureus DHFR complexed with NADPH and AR-101x-ray diffractionX——
3FYWStaph. aureus DHFR complexed with NADPH and ar-101x-ray diffractionX——
3I8AStaphylococcus aureus H30N, F98Y Dihydrofolate Reductase complexed with NADPH and…x-ray diffractionX——
3I8AStaphylococcus aureus H30N, F98Y dihydrofolate reductase complexed with NADPH and…x-ray diffractionX——
3LG4Staphylococcus aureus V31Y, F92I mutant dihydrofolate reductase complexed with NADPH and…x-ray diffractionA, B——
3LG4Staphylococcus aureus V31Y, F92I mutant dihydrofolate reductase complexed with NADPH and…x-ray diffractionA, B——
3M08Wild Type Dihydrofolate Reductase from Staphylococcus aureus with inhibitor RAB1x-ray diffractionA——
3M08Wild type dihydrofolate reductase from staphylococcus aureus with inhibitor RAB1x-ray diffractionA——
3M09F98Y TMP-resistant Dihydrofolate Reductase from Staphylococcus aureus with inhibitor RAB1x-ray diffractionA——
3M09F98Y tmp-resistant dihydrofolate reductase from staphylococcus aureus with inhibitor RAB1x-ray diffractionA——
3SGYStaphylococcus aureus Dihydrofolate Reductase complexed with NADPH and…x-ray diffractionA, B——
3SGYStaphylococcus aureus dihydrofolate reductase complexed with NADPH and…x-ray diffractionA, B——
3SH2Staphylococcus aureus Dihydrofolate Reductase complexed with NADPH and…x-ray diffractionA, B——
3SH2Staphylococcus aureus dihydrofolate reductase complexed with NADPH and…x-ray diffractionA, B——
3SQYS. aureus Dihydrofolate Reductase complexed with novel 7-aryl-2,4-diaminoquinazolinesx-ray diffractionX——
3SQYS. aureus dihydrofolate reductase complexed with novel 7-aryl-2,4- diaminoquinazolinesx-ray diffractionX——
3SR5S. aureus Dihydrofolate Reductase complexed with novel 7-aryl-2,4-diaminoquinazolinesx-ray diffractionX——
3SR5S. aureus dihydrofolate reductase complexed with novel 7-aryl-2,4- diaminoquinazolinesx-ray diffractionX——
3SRQS. aureus Dihydrofolate Reductase complexed with novel 7-aryl-2,4-diaminoquinazolinesx-ray diffractionX——
3SRQS. aureus dihydrofolate reductase complexed with novel 7-aryl-2,4- diaminoquinazolinesx-ray diffractionX——
3SRRS. aureus Dihydrofolate Reductase complexed with novel 7-aryl-2,4-diaminoquinazolinesx-ray diffractionX——
3SRRS. aureus dihydrofolate reductase complexed with novel 7-aryl-2,4- diaminoquinazolinesx-ray diffractionX——
3SRSS. aureus Dihydrofolate Reductase complexed with novel 7-aryl-2,4-diaminoquinazolinesx-ray diffractionX——
3SRSS. aureus dihydrofolate reductase complexed with novel 7-aryl-2,4- diaminoquinazolinesx-ray diffractionX——
3SRUS. aureus Dihydrofolate Reductase complexed with novel 7-aryl-2,4-diaminoquinazolinesx-ray diffractionX——
3SRUS. aureus dihydrofolate reductase complexed with novel 7-aryl-2,4- diaminoquinazolinesx-ray diffractionX——
3SRWS. aureus Dihydrofolate Reductase complexed with novel 7-aryl-2,4-diaminoquinazolinesx-ray diffractionX——
3SRWS. aureus dihydrofolate reductase complexed with novel 7-aryl-2,4- diaminoquinazolinesx-ray diffractionX——
4FGGS. aureus dihydrofolate reductase co-crystallized with propyl-DAP isobutenyl-dihydrophthalazine…x-ray diffractionA——
4FGGS. aureus dihydrofolate reductase co-crystallized with propyl-dap isobutenyl-dihydrophthalazine…x-ray diffractionA——
4FGHS. aureus dihydrofolate reductase co-crystallized with ethyl-DAP isobutenyl-dihydrophthalazine…x-ray diffractionA——
4FGHS. aureus dihydrofolate reductase co-crystallized with ethyl-dap isobutenyl-dihydrophthalazine…x-ray diffractionA——
4LAEStructure-Based Design of New Dihydrofolate Reductase Antibacterial Agents…x-ray diffractionX——
4LAEStructure-based design of new dihydrofolate reductase antibacterial agents…x-ray diffractionX——
4LAGStructure-Based Design of New Dihydrofolate Reductase Antibacterial Agents…x-ray diffractionX——
4LAGStructure-based design of new dihydrofolate reductase antibacterial agents…x-ray diffractionX——
4LAHStructure-Based Design of New Dihydrofolate Reductase Antibacterial Agents…x-ray diffractionX——
4LAHStructure-based design of new dihydrofolate reductase antibacterial agents…x-ray diffractionX——
4LEKStructure-Based Design of New Dihydrofolate Reductase Antibacterial Agents…x-ray diffractionX——
4LEKStructure-based design of new dihydrofolate reductase antibacterial agents…x-ray diffractionX——

30 records more on the page itself.

Ligands

  • NAP · Nadp nicotinamide-adenine-dinucleotide phosphate · in 14 records
  • XNP · Tricyclic NADPH · in 5 records
  • 06U · 6-ethyl-5-{(3R)-3-[3-methoxy-5-(pyridin-4-yl) phenyl]but-1-yn-1-yl}pyrimidine-2,4-diamine · in 3 records
  • NDW · alpha-NADPH · in 2 records
  • OWJ · (2E)-3-{5-[(2,4-diaminopyrimidin-5-yl)methyl]-2,3-dimethoxyphenyl}-1-[(1S)-1-(3,5-dimethylphenyl) phthalazin-2(1H)-yl]prop-2-en-1-one · in 2 records
  • OWV · (2E)-3-{5-[(2,4-diaminopyrimidin-5-yl)methyl]-2,3-dimethoxyphenyl}-1-[(1S)-1-(pentan-3-yl)-3,4-dihydrophthalazin-2(1H)-yl]prop-2-en-1-one · in 2 records
  • U06 · 4-[3-[3-[2,4-bis(azanyl)-6-ethyl-pyrimidin-5-yl]prop-2-ynyl]-4-methoxy-phenyl]benzoic acid · in 2 records
  • G8J · 6-ethyl-5-{(3S)-3-[2-methoxy-5-(pyridin-4-yl) phenyl]but-1-yn-1-yl}pyrimidine-2,4-diamine · in 1 record
  • MMV · 3-(2-{3-[(2,4-diamino-6-ethylpyrimidin-5-yl) oxy]propoxy}phenyl)propanoic acid · in 1 record
  • O71 · (4-{6-[(2S)-4-(2,4-diamino-6-ethylpyrimidin-5-yl)but-3-yn-2-yl]-2H-1,3-benzodioxol-4-yl}phenyl)acetic acid · in 1 record
  • OWG · 3-{5-[(2,4-diaminopyrimidin-5-yl)methyl]-2,3-dimethoxyphenyl}-1-[(1S)-6,7-dimethoxy-1-(4-methoxyphenyl)-3,4-dihydrophthalazin-2(1H)-yl]propan-1-one · in 1 record
  • OWM · (2E)-1-[(1R)-1-cyclopropyl-6,7-dimethoxyphthalazin-2(1H)-yl]-3-{5-[(2,4-diaminopyrimidin-5-yl)methyl]-2, 3-dimethoxyphenyl}prop-2-en-1-one · in 1 record
  • OWP · (2E)-1-[(1S)-1-benzylphthalazin-2(1H)-yl]-3-{5-[(2,4-diaminopyrimidin-5-yl)methyl]-2,3-dimethoxyphenyl}prop-2-en-1-one · in 1 record
  • OWS · (2E)-3-{5-[(2,4-diaminopyrimidin-5-yl)methyl]-2,3-dimethoxyphenyl}-1-[(1S)-1-(4-methylphenyl)phthalazin-2(1H)-yl]prop-2-en-1-one · in 1 record
  • R0Y · (2E)-1-[(1S)-1-cyclopropyl-6,7-dimethoxy-3,4-dihydrophthalazin-2(1H)-yl]-3-{5-[(2,4-diaminopyrimidin-5-yl)methyl]-2,3-dimethoxyphenyl}prop-2-en-1-one · in 1 record
  • U75 · 4-[3-[3-[2,4-bis(azanyl)-6-ethyl-pyrimidin-5-yl]prop-2-ynyl]-5-methoxy-phenyl]benzoic acid · in 1 record

Experiment against prediction

Elsewhere

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.